AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2018
Jan 16, 2018
284_dirs_2018-01-16_2b702303-d1a2-4ba3-8733-9780b2f098d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-01-12
Reporting Person: GRADDICK WEIR MIRIAN M (Exe V-P, HR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-12 | Common Stock | S | 5000.0000 | $58.0000 | Disposed | 101484.3190 | Direct |
| 2018-01-16 | Common Stock | M | 52000.0000 | $44.3000 | Acquired | 153484.3190 | Direct |
| 2018-01-16 | Common Stock | S | 8000.0000 | $61.6300 | Disposed | 145484.3190 | Direct |
| 2018-01-16 | Common Stock | S | 52000.0000 | $61.6300 | Disposed | 93484.3190 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-16 | Stock Option (right to buy) | $44.3000 | M | 52000.0000 | Disposed | 2018-02-28 | Common Stock (52000.0000) | Direct |
Footnotes
F1: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
F2: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F3: Holdings include shares acquired in dividend reinvestment transactions.
F4: The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30